Cabaletta Bio Inc: Financial Report Reveals Market Insightsby Mark Eisenberg 30.03.2024Delve into a comprehensive financial analysis of Cabaletta Bio Inc, a key player in the NASDAQ exchange, with a strong ...
AI Transforms Online Pharmacy: Speed, Accuracy, Convenienceby Lilu Anderson 29.03.2024Amazon Pharmacy is leveraging AI for its same-day delivery service expansion in New York City and Los Angeles. AI helps ...
Congressional Plans for WuXi: Implications for Biotechby Lilu Anderson 29.03.2024Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
China’s AI Propaganda Mocks American Dreamby Lilu Anderson 29.03.2024The article discusses the declining American Dream and how people are increasingly seeking better opportunities outside the United States. This ...
Boundless Bio Makes $100M IPO Debut on Nasdaqby Mark Eisenberg 28.03.2024Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Moleculin Biotech Stock Coverage and Analysis at StockNewsby Mark Eisenberg 28.03.2024Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Moleculin Biotech Stock Receives “Sell” Rating – Analystsby Mark Eisenberg 28.03.2024Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...
Akanda Corp. Financial Report: Growth Potential or Risk?by Mark Eisenberg 28.03.2024Learn about Akanda Corp. (AKAN) in this informative finance report. Discover key financial data, market performance, and future outlook for ...
Merck Stock Hits New High; Dow Outperformsby Mark Eisenberg 28.03.2024Stock and bond markets will be closed on Good Friday. Get expert advice straight to your e-mail for profitable opportunities. ...
NextCure, Inc.: Promising Growth Potential or Risky Investment?by Mark Eisenberg 28.03.2024NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.